Journal Information
Share
Share
Download PDF
More article options
Visits
128
Special article
Full text access
Physiological impact of the facial mask at rest (2): Modification of Cardiac Variability (HRV) in young athletes
Visits
128
Ignasi de Yzaguirre Mauraa,
Corresponding author
14521iym@comb.cat

Corresponding author.
, Jaume Escoda i Moraa, Mauricio Monacob, Gonzalo Graziolic, Jordi Santiagoa, Daniel Brotons i Cuixarta
a Unitat d'Esport i Salut, Generalitat of Catalunya, (Esplugues de Llobregat), 08950 Barcelona, Spain
b Aspetar Orthopedic and Sports Medicine Hospital, Qatar
c Àptima Center Clínic, Mutua Terrassa, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. Physiological profile of study participants.
Table 2. Heart rate variability results. Total number of subjects studied, men and women.
Table 3. Heart rate variability results. Women only.
Table 4. Heart rate variability results. Men only.
Show moreShow less
Abstract
Introduction

During the imperative mandate of mask-wearing during the COVID-19 pandemic, our study aimed to elucidate the physiological repercussions stemming from hypoxia and hypercapnia induced by facemasks during periods of rest. Specifically, we investigated the influence of facemasks on heart rate variability (HRV) within a cohort of young athletes.

Material and methods

Experimental study in which 56 competitive adolescent athletes (55 % female) were evaluated. The heart rate data was recorded during 8-min, in meditative rest while seated. We conducted a comprehensive analysis of heart rate variability, examining both a 4-min segment and a 100-beat window. Comparisons were made between data recorded when subjects wore facemasks and when they breathed freely without masks. Data analysis was performed utilizing the Polar ProTrainer 5 software.

Results

The results showed relevant statistical differences at the level of cardiac variability (HRV): a) Heart Rate (mask: 70.5 ± 11.3 bpm vs no mask: 71.4 ± 12 bpm; p < 0.043. b) RMSSD (Mask: 56.8 ± 41.1 ms vs no mask: 48.9 ± 30.8 ms p < 0.002). c) RMSSD only 100 beats (mask: 58.1 ± 42.0 ms vs no mask: 46.7 ± 28.4 ms; p < 0.0001).

Conclusions

Upon removing the facemask while maintaining meditative rest, 86 % of the subjects exhibited a distinct sympathetic response during the subsequent 5-min period. Notably, in 13 % of participants, this sympathetic response persisted across both phases of the study. Furthermore, the analysis of Ultra-Short-Term Cardiac Variability based on 100 beats accentuated the significance of the observed differences.

Keywords:
Hypoxia
Hypercapnia
Rarefied air
Facial mask
Heart rate variability (HRV)
Full Text
Introduction

The aim of this study is to replicate the findings published, regarding the modifications in Cardiac Variability induced by the use of facemasks for COVID-19 prevention, as detected through routine electrocardiograms, during the annual sports medicine screening.1 This work significantly increases the subject pool and incorporates a resting scenario to enable the investigation of Cardiac Variability under both masked and unmasked conditions. These findings add to the studies of the impact of hypercapnic hypoxia and rarefied air in various situations carried out, since 2008.2–6

Material and method

We assessed 56 adolescent athletes (55 % female) including 9 who had recovered from COVID-19 and were in good athletic shape, as can be seen in Table 1. We measured their heartbeats in milliseconds using a Polar S800i heart rate monitor during an 8-min session of relaxation with soothing music while sitting.7 Participants wore Type IIR facemasks (model NM12458) adjusted with a post-cervical tensioner. We conducted a double analysis of heart variability (HRV) for 4 min and 100 beats, comparing results with and without masks. Data were analyzed using Polar ProTrainer5 software, prioritizing robust scientific knowledge on cardiac variability.8–10

Table 1.

Physiological profile of study participants.

  Man  women  p< 
Age (years)  18.5 ± 5.9  15.2 ± 2.35  0.02 
Weight (Kg)  64.4 ± 8.6  57.6 ± 10.2  0.01 
Height (m)  1.752 ± 0.09  1.70 ± 0.08  N.S. 
BMI  20.9 ± 1.73  19.6 ± 2.23  0.02 

BMI: Body Mass Index.

Statistical study

Continuous variables were presented as means and standard deviations. A paired two-tailed T-test was employed to assess the significance of differences observed. When comparing the "men" and "women" groups, the variance of each group was determined due to the unpaired nature of the data, ensuring appropriate adjustment of the T-test.

The primary variables under scrutiny encompassed heart rate (HR) and the square root of the mean of the squares of the successive differences between adjacent normal beats (RMSSD).10

Results

In relation to cardiac variability (HRV), an analysis of 4 min of cardiac recording unveiled significant findings. Key parameters are as follows:

  • 1.

    Heart rate exhibited a statistically significant increase upon subjects' removal of face masks: Heart Rate (mask: 70.5 ± 11.3 bpm vs no mask: 71.4 ± 12 bpm).

  • 2.

    The square root of the mean of the squares of the successive differences between adjacent normal beats witnessed a highly significant decrease upon releasing subjects from face masks: RMSSD (Mask: 56.8 ± 41.1 ms vs no mask: 48.9 ± 30.8 ms).

Additional HRV parameters derived from the 4-min analysis are outlined below, as can be seen in Table 2, Table 3 and Table 4:

  • a) The Relaxation index analyzed using Polar (RLX), expressed in milliseconds, showcased a notable decrease upon subjects' mask removal (Mask: 36.1 ± 21.7 ms vs no mask: 31.4 ± 16.6 ms).

  • b) The width of the ellipse in the Poincaré diagram (SD1) exhibited a significant decrease when subjects were unmasked (Mask: 40.2 ± 29.1 ms vs no mask: 34.6 ± 21.8 ms).

  • c) The percentage of normal, successive heartbeats with a difference greater than 50 milliseconds (pNN50) demonstrated a significant decrease upon mask removal (Mask: 13.2 ± 10.9 % vs no mask: 11.2 ± 9.6 %).

  • d) Analysis in the frequency domain revealed a significant decrease in the high-frequency band (HF) upon subjects' mask removal (Mask: 1826 ± 2615 Hz vs no mask: 1339 ± 1580 Hz).

Table 2.

Heart rate variability results. Total number of subjects studied, men and women.

Total: (Women + Men) n: 56       
  mask  Without Mask   
  Average  Average  p< 
Minimum RR interval (ms)  711.2 ± 106  712.5 ± 141  N/S 
Mean RR interval (ms)  874.2 ± 151.5  865.8 ± 158.1  N/S 
Maximum RR interval (ms)  1088 ± 266.6  1068 ± 205  N/S 
RLX baseline  36.1 ± 21.7  31.4 ± 16.6  0.009 
SDNN (ms)  69.7 ± 33.9  68.1 ± 34.5  N/S 
max/min ratio  1.5 ± 0.3  1.5 ± 0.3  N/S 
RR weighted average (ms)  880.6 ± 153.7  872.3 ± 159.8  N/S 
SD1  40.2 ± 29.1  34.6 ± 21.8  0.002 
SD2  88.1 ± 39.6  88.8 ± 44.7  N/S 
RMSSD (ms)  56.8 ± 41.1  48.9 ± 30.8  0.002 
pNN50 ( %)  13.2 ± 10.9  11.2 ± 9.6  0.002 
SD2/SD1  2.6 ± 1  2.9 ± 0.9  0.013 
Total power (0.003–0.400 Hz)  7544 ± 9577  6359 ± 6459  N/S 
VLF (0.003–0.040 Hz)  3397 ± 6146  2818 ± 2569  N/S 
LF (0.040–0.150 Hz)  2321 ± 3532  2203 ± 3123  N/S 
HF (0.150–0.400 Hz)  1826 ± 2615  1339 ± 1580  0.018 
LF/HF ratio  218.1 ± 214.7  238 ± 199  N/S 
HR  70.5 ± 11.3  71.4 ± 12  0.043 
HRV ultrashort (100 beats)       
amplitude 100 (ms)  331.8 ± 126  314.5 ± 118.9  N/S 
mode 100 ( %)  36.3 ± 14.6  38.3 ± 13.6  N/S 
SD1 100  40.3 ± 29.9  32.9 ± 20.2  0.0003 
SD2 100  82.6 ± 41.1  80.7 ± 40.6  N/S 
SD2/SD1 100  2.44 ± 1.0  2.77 ± 0.9  0.0022 
RMSSD 100 (ms)  58.1 ± 42.0  46.7 ± 28.4  0.0001 

RLX baseline: Relaxation rate analyzed using PolarR (RLX), expressed in milliseconds. SDNN (ms): standard deviation of "n" normal intervals. SD1: The width of the ellipse in the Poincaré diagram, relative to successive "rr". SD2: Length of the ellipse in the Poincaré diagram. RMSSD (ms): The square root of the mean of the squares of the successive differences between adjacent normal beats. pNN50 ( %): the proportion of normal and successive rr intervals, greate than 50 milliseconds, divided by total number of intervals. Total power (0.003–0.400 Hz): VLF (0.003–0.040 Hz): the very low frequency (VLF) from 0.0033 to 0.04 Hz. LF (0.040–0.150 Hz): HF (0.150–0.400 Hz): high frequency from 0.15 to 0.4 Hz. HR: heartbeat frequency. HRV ultrashort (100 beats): Cardiac variability performed with 100 successive beats. Amplitude 100 (ms): Amplitude of the normal curve made with 100 successive beats. Mode 100 ( %): Statistical mode of the normal curve made with 100 successive beats, expressed in percentage.

Table 3.

Heart rate variability results. Women only.

Women n: 31       
  Mask  Without Mask   
  Average  Average  p< 
Minimum RR interval (ms)  681.9 ± 93  681.9 ± 102.8  N/S 
Mean RR interval (ms)  838.2 ± 119  834.3 ± 118.3  N/S 
Maximum RR interval (ms)  1060 ± 264  1019.6 ± 152.6  N/S 
RLX baseline  33.7 ± 18.4  31.2 ± 15  N/S 
SDNN (ms)  69.3 ± 34.4  64.9 ± 32.8  N/S 
max/min ratio  1.6 ± 0.3  1.5 ± 0.2  N/S 
RR weighted average (ms)  845 ± 122  841.2 ± 120  N/S 
SD1  39.6 ± 30.8  34.2 ± 21.5  0.045 
SD2  87.3 ± 39.2  91.1 ± 42  N/S 
RMSSD (ms)  56.1 ± 43.5  48.4 ± 30.5  0.045 
pNN50 ( %)  12.1 ± 10.5  10.7 ± 9.3  N/S 
SD2/SD1  2.6 ± 0.8  2.9 ± 0.8  0.015 
Total power (0.003–0.400 Hz)  8254 ± 11550  6337 ± 6467  N/S 
VLF (0.003–0.040 Hz)  41001 ± 8160  2680.6 ± 2288  N/S 
LF (0.040–0.150 Hz)  2154 ± 3614  2216.1 ± 3417  N/S 
HF (0.150–0.400 Hz)  2000 ± 3088  1441.2 ± 1770  N/S 
LF/HF ratio  167 ± 140  207.7 ± 176.7  N/S 
HR  72.9 ± 9.9  73.3 ± 9.9  N/S 
HRV ultrashort (100 beats)       
amplitude 100 (ms)  315.5 ± 121.1  300 ± 101  N/S 
mode 100 ( %)  37.9 ± 15  36.5 ± 11.9  N/S 
SD1 100  38.1 ± 30.8  32 ± 19.1  0.044 
SD2 100  79.2 ± 43.6  79.6 ± 38.9  N/S 
SD2/SD1 100  2.3 ± 0.8  2.7 ± 0.8  0.020 
RMSSD 100 (ms)  55.6 ± 44.3  46 ± 27.3  0.030 

RLX baseline: Relaxation rate analyzed using PolarR (RLX), expressed in milliseconds. SDNN (ms): standard deviation of "n" normal intervals. SD1: The width of the ellipse in the Poincaré diagram, relative to successive "rr". SD2: Length of the ellipse in the Poincaré diagram. RMSSD (ms): The square root of the mean of the squares of the successive differences between adjacent normal beats. pNN50 ( %): the proportion of normal and successive rr intervals, greate than 50 milliseconds, divided by total number of intervals. Total power (0.003–0.400 Hz): VLF (0.003–0.040 Hz): the very low frequency (VLF) from 0.0033 to 0.04 Hz. LF (0.040–0.150 Hz): HF (0.150–0.400 Hz): high frequency from 0.15 to 0.4 Hz. HR: heartbeat frequency. HRV ultrashort (100 beats): Cardiac variability performed with 100 successive beats. Amplitude 100 (ms): Amplitude of the normal curve made with 100 successive beats. Mode 100 ( %): Statistical mode of the normal curve made with 100 successive beats, expressed in percentage.

Table 4.

Heart rate variability results. Men only.

Men n = 25       
  Mask  Without Mask   
  Average  Average  p< 
Minimum RR interval (ms)  744 ± 111.7  747 ± 169.8  N/S 
Mean RR interval (ms)  914.3 ± 174.4  901.0 ± 189.5  N/S 
Maximum RR interval (ms)  1119 ± 271  1117.3 ± 243.1  N/S 
RLX baseline  38.8 ± 25  31.5 ± 18.5  0.024 
SDNN (ms)  70.2 ± 34  66.7 ± 37  N/S 
max/min ratio  1.5 ± 0.3  1.5 ± 0.4  N/S 
RR weighted average (ms)  920.3 ± 177.3  907.0 ± 102  N/S 
SD1  40.7 ± 20.7  35.0 ± 22.5  0.017 
SD2  88.9 ± 40.8  86.2 ± 48.2  N/S 
RMSSD (ms)  57.6 ± 35.1  49.5 ± 31.8  0.017 
pNN50 ( %)  14.4 ± 11.5  11.7 ± 10  0.009 
SD2/SD1  2.7 ± 1.2  2.8 ± 1  N/S 
Total power (0.003–0.400 Hz)  6751 ± 6888  6383 ± 6578  N/S 
VLF (0.003–0.040 Hz)  2611 ± 2409  2971 ± 2888  N/S 
LF (0.040–0.150 Hz)  2507 ± 3500  2188 ± 2826  N/S 
HF (0.150–0.400 Hz)  1633 ± 2005  1225 ± 1364  N/S 
LF/HF ratio  275 ± 267  271 ± 220  N/S 
HR  67.8 ± 12.3  69.3 ± 13.9  0.047 
HRV ultrashort (100 beats)       
amplitude 100 (ms)  350 ± 131  331 ± 136  N/S 
mode 100 ( %)  34.5 ± 14.2  40.2 ± 15.4  0.0006 
SD1 100  43 ± 29  33.9 ± 22  0.0011 
SD2 100  85.9 ± 38.9  82.0 ± 43.1  N/S 
SD2/SD1 100  2.5 ± 1.2  2.8 ± 1.0  N/S 
RMSSD 100 (ms)  60.8 ± 39.9  47.4 ± 30.1  0.0004 

RLX baseline: Relaxation rate analyzed using PolarR (RLX), expressed in milliseconds. SDNN (ms): standard deviation of "n" normal intervals. SD1: The width of the ellipse in the Poincaré diagram, relative to successive "rr". SD2: Length of the ellipse in the Poincaré diagram. RMSSD (ms): The square root of the mean of the squares of the successive differences between adjacent normal beats. pNN50 ( %): the proportion of normal and successive rr intervals, greate than 50 milliseconds, divided by total number of intervals. Total power (0.003–0.400 Hz): VLF (0.003–0.040 Hz): the very low frequency (VLF) from 0.0033 to 0.04 Hz. LF (0.040–0.150 Hz): HF (0.150–0.400 Hz): high frequency from 0.15 to 0.4 Hz. HR: heartbeat frequency. HRV ultrashort (100 beats): Cardiac variability performed with 100 successive beats. Amplitude 100 (ms): Amplitude of the normal curve made with 100 successive beats. Mode 100 ( %): Statistical mode of the normal curve made with 100 successive beats, expressed in percentage.

Upon conducting data analysis solely with 100 beats, both with and without masks, the results exhibited even greater statistical significance:

  • a) SD1 only 100 beats (mask: 40.3 ± 29.9 ms vs no mask: 32.9 ± 20.2 ms; p < 0.0003).

  • b) SD2/SD1 only 100 beats (mask: 2.44 ± 1.0 ratio vs no mask: 2.77 ± 0.9 ratio; p < 0.0022).

  • c) RMSSD only 100 beats (mask: 58.1 ± 42.0 ms vs no mask: 46.7 ± 28.4 ms; p < 0.0001).

Discussion

In our previous investigation,1 we elucidated the effect of mask usage on the neurovegetative equilibrium of the participants, resulting in an increased predominance of the parasympathetic component.

That initial study was conducted utilizing standard 10-s electrocardiograms (ECG) obtained while the subjects wore mandatory masks during the pandemic and was retrospectively compared with ECG data collected in the previous year.

The current study aimed to validate the results of the prior investigation by expanding the sampling duration of heart rate data to 4 min, both with the subject wearing a mask and breathing freely without a mask while at rest.

Likewise, the statistical analysis was replicated using series of 100 heartbeats to assess the efficacy of this "ultrashort" method, as well as various sphygmometry techniques (histogram of heart rate distribution with a 50 ms range) advocated by S. Tíjvinski15 in 1991. Additionally, the correlational rhythmogram (also known as Scaterogram, Poincaré diagram...) proposed by E. Zemtsovski et al. in 1977 was employed.16

Our findings elucidate the degree to which cardiac variability predominantly emerges as an adaptive reaction to subtle hypoxic and hypercapnic circumstances induced by the utilization of infection prevention masks. This adaptation demonstrates statistical significance across all pivotal variables scrutinized in our study, notably heart rate (HR) and the analysis of the interval between successive beats (RMSSD). Our results are consistent with the ultrashort methodologies advocated by Nunan et al.11

Contributions of our research reaffirm the conclusions drawn by our team regarding the impact of masks on neurovegetative balance.1 Furthermore moreover, it validates the efficacy and sensitivity of ultrashort methodologies in assessing heart rate variability (HRV),11–13 particularly the traditional 100-beat method.

Limitations of our study: In our investigation, the cohort consisting of "n = 31″ women had lower values for the primary parameters investigated: heart rate and RMSSD, in comparison to their male counterparts. However, it is noteworthy that the female participants were from a younger age group relative to the male cohort.

We attribute the observed discrepancy in adaptation to anatomical distinctions between the male and female subjects, rather than age-related effects. Specifically, it is acknowledged that individuals with greater stature typically possess a larger anatomical dead space. Consequently, in taller individuals, the dead space of the mask represents a relatively smaller proportion relative to their height.6

Our study focuses on short-term assessments conducted over durations of 5 min and 100 heartbeats. Consequently, our research lacks the prognostic capability inherent in 24-h follow-up studies, which examine broader outcomes such as morbidity or mortality. Additionally, our research has not delved into whether hypoxic and hypercapnic conditions induced by mask wearing exert any influence on blood pressure, a question addressed by findings from previous studies.4,14

Conclusions

Upon removing facemasks during meditative rest, 86 % of subjects exhibited a clear sympathetic response for 5 min. 13 % showed consistent sympathetic responses throughout both phases of the study. Upon analyzing Ultra-Short-Term Cardiac Variability based on 100 beats, the significance of these observations became even more pronounced.

Our novel investigation, characterized by meticulous "RR" interval measurement over 4 min, reveals an increased parasympathetic predominance during facemask use at rest, influencing the autonomic loop regulation.

References
[1]
I. de Yzaguirre i Maura, D.D. Zabala, M. Monaco, J.S. Garcia, M.R. Miralles, G. Grazioli.
The use of facemasks and the impact on heart rate variability during baseline ECG.
[2]
F. Pifarré, D.D. Zabala, G. Grazioli, I. de Yzaguirre i Maura. COVID-19 and mask in sports. https://doi.org/10.1016/j.apunsm.2020.06.002.
[3]
I. De Yzaguirre, J. Vives, J.A. Gutiérrez, D. Brotons, A. Tramullas.
Ergometry and climate change.Notes.
Medicina de l'Esport, 45 (2010), pp. 219-225
[4]
I. De Yzaguirre Maura, G. Grazioli, D.F.-C. Mónica, D. Dulanto Zabala, M. Sitges, J.A. Gutierrez Rincon.
Effect of rarefied air in a Mediterranean cave at cardiovascular level in humans».
Medicina De l'esport, 51 (2016), pp. 40-47
[5]
I. De Yzaguirre Maura, J. Escoda, J. Bosch, J. Gutierrez Rincon, D. Dulanto Zabala, R. Segura Cardona.
Adaptation to the rarefied air of abysses and caves. A laboratory study.
Medicina De l'esport, 43 (2008), pp. 135-141
[6]
I. de Yzaguirre et al. COVID-19: analysis of cavitary air inspired through a mask, in competitive adolescent athletes. https://doi.org/10.1016/j.apunsm.2021.100349.
[8]
J. Dituri, F. Siddiqi, R. Frisina.
Real-time heart rate variability analysis as a means of hypercapnia detection.
Undersea Hyperb Med, 46 (2019), pp. 503-507
[9]
Baevsky, R. M. Chernikova, A. G. (2017). Heart rate variability analysis: physiological foundations and main methods. Cardiometry. 66–76. https://doi.org/10.12710/cardiometry.2017.10.6676.
[10]
F. Shaffer, J.P. Ginsberg.
An Overview of Heart Rate Variability Metrics and Norms.
Front Public Health, 5 (2017 Sep 28), pp. 258
[11]
D. Nunan, G.R.H. Sandercock, E.A. Brodie.
A quantitative systematic review of normal values for short term heart rate variability in healthy adults.
Pacing Clin Electrophysiol, 33 (2010), pp. 1407-1417
[12]
L. Salahuddin, J. Cho, M.G. Jeong, D. Kim.
Ultra short term analysis of heart rate variability for monitoring mental stress in mobile settings.
Conf Proc IEEE Eng Med Biol Soc, pp. 4656-4659
[13]
H.J. Baek, C.H. Cho, J. Cho, J.M. Woo.
Reliability of ultra-short-term analysis as a surrogate of standard 5-min analysis of heart rate variability.
Telemed JE Health, 21 (2015), pp. 404-414
[14]
S. Brown, M.J. Barnes, T. Mundel.
Effects of hypoxia and hypercapnia on human HRV and respiratory sinus arrhythmia.
Acta Physiol Hung, 101 (2014), pp. 263-272
[15]
S.B. Tíkhvinski.
Khrushchev SV Children's Sports Medicine.
Moscow, (1991), pp. 559-560
[16]
Zemtsovski E.V., Baranovski A.L., Vasiliev. New method to record heart rate in athletes. Theory Pract Phys Cult. 1977, 6. p 1593–1599.

Study carried out without scholarships or financial budget.

Original content, which has not been presented at any public event.

The current study was carried out in the Metropolitan Area of Barcelona (spain), in the physiology laboratory of the Sports and Health Unit of the General Secretariat of Sports (Government of Catalonia).

The study took place in the Barcelona Metropolitan Area, during the COVID-19 pandemic (between 3/8/2021 to 6/15/2022). The laboratory air composition was: O2: 20.9 % and CO2: 578 ± 76 ppm. Our procedures complied with ethical guidelines from the Responsible Committee for Human Experimentation at Consell Catalla de L'Esport and with the principles of the 1975 Helsinki declaration.

We extend gratitude to the Sports and Health Unit of the Government of Catalonia and the young athletes and families at the Blume Residence in Esplugues de Llobregat (Barcelona) for their consent and collaboration.

The study has been favorably reported by the ethics committee of the sports administration of Catalonia (certificate: 018 / CEICGC / 2021).

Download PDF
Apunts Sports Medicine
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?